Merck Speciality gets CDSCO Panel Nod To study anti-cancer drug Avelumab Dr. Divya Colin22 March 2024 5:45 PM ISTNew Delhi: The drug major Merck Speciality has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Pfizer Gets CDSCO Panel Nod to Study Anti-cancer Drug PF-07220060 Dr. Divya Colin21 March 2024 6:00 PM ISTNew Delhi: The drug major Pfizer has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO Panel grants GSK's Updated Prescribing Information for Antibiotic FDC of Amoxicillin, Clavulanic acid Dr. Divya Colin21 March 2024 5:45 PM ISTNew Delhi: The drug major GSK has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
Submit Interim Safety, Efficacy Data: CDSCO Panel Tells Novartis on Crizanlizumab Dr. Divya Colin20 March 2024 6:00 PM ISTNew Delhi: Reviewing the status of the ongoing studies of Crizanlizumab concentrate for solution for infusion 10mg/mL (100mg/10mL), the Subject Expert...
Pfizer Gets CDSCO Panel Nod To study Osivelotor in sickle cell disease Dr. Divya Colin19 March 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to drug...
CDSCO Panel Rejects Akum Pharma's Clonazepam-Duloxetine Combination Drug Dr. Divya Colin18 March 2024 6:00 PM ISTNew Delhi: Reviewing the justification provided by the drug major Akum Pharmaceutical concerning the fixed-dose combination (FDC) Clonazepam plus...
AstraZeneca Gets CDSCO Panel Nod to Study anticancer drug Volrustomig Dr. Divya Colin17 March 2024 6:00 PM ISTNew Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO Panel Approves Sanofi's Protocol Amendment Proposal For Study of SAR443122 in Ulcerative Colitis Dr. Divya Colin17 March 2024 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Need More Justification: CDSCO Panel rejects J&J protocol amendment proposal for Teclistamab study Dr. Divya Colin17 March 2024 5:45 PM ISTNew Delhi: Citing that more justification is required, the Subject Expert Committee SEC functional under the Central Drug Standard Control...
Modify Clinical study protocol of Iptacopan study in aHUS: CDSCO Panel Tell Novartis Dr. Divya Colin17 March 2024 5:15 PM ISTNew Delhi: Reviewing the Phase IIIb clinical trial study protocol of Iptacopan, the Subject Expert Committee (SEC) functional under the Central...
CDSCO Panel Grants Roche's Protocol Amendment Proposal For Crovalimab study Dr. Divya Colin16 March 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
CDSCO Panel grants Pfizer's Protocol Amendment for Anti-cancer Drug Palbociclib study Dr. Divya Colin16 March 2024 4:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
